# The Brain Fatigue Syndrome—Symptoms, Probable Definition, and Pathophysiological Mechanisms

**Authors:** Birgitta Johansson, Lars Rönnbäck

PMC · DOI: 10.3390/jcm14103271 · Journal of Clinical Medicine · 2025-05-08

## TL;DR

Brain Fatigue Syndrome is a condition caused by brain injuries or diseases, marked by severe fatigue, cognitive issues, and long recovery times, with potential cellular mechanisms like astrocyte and mitochondrial dysfunction.

## Contribution

The paper introduces 'Brain Fatigue Syndrome' as a new term to describe a cluster of symptoms linked to brain-related fatigue and proposes potential cellular mechanisms.

## Key findings

- Brain Fatigue Syndrome can be identified using the Mental Fatigue Scale.
- Potential mechanisms include astrocyte dysfunction, mitochondrial issues, and blood-brain barrier disruption.
- Symptoms often resolve with healing but may persist in some individuals.

## Abstract

Fatigue is a common consequence of traumatic brain injury, neurological diseases or developmental disorders, and systemic inflammatory diseases, including autoimmune conditions that affect the brain. This condition is characterized by reduced endurance for cognitive tasks, diminished quality of life, and impaired work capacity. In addition to cognitive difficulties, individuals often experience disproportionately long recovery times after demanding tasks, emotional instability, stress sensitivity, sensory sensitivity, impaired ability to initiate activities, and sleep disturbances. Tension headaches frequently occur when the brain is excessively activated by mental activity. In this paper, we propose the term “Brain Fatigue Syndrome” (BFS) as a collective name for the symptoms closely associated with this pathological fatigue resulting from brain impact. BFS can be identified through interviews and measured using the self-assessment instrument, the Mental Fatigue Scale (MFS). We suggest potential underlying mechanisms at the cellular level for the BFS symptom complex, including astrocyte dysfunction with impaired glutamate signaling and glucose uptake, mitochondrial dysfunction, blood–brain barrier dysfunction, and the activation of microglia and mast cells. In conclusion, BFS suggests a general brain impact. The symptoms associated with BFS typically resolve when the injury or disease heals. However, in some individuals, BFS persists even after the injury or illness has ostensibly healed.

## Linked entities

- **Diseases:** traumatic brain injury (MONDO:0858950)

## Full-text entities

- **Diseases:** traumatic brain injury (MESH:D000070642), inflammatory diseases (MESH:D007249), cognitive difficulties (MESH:D003072), Tension headaches (MESH:D018781), work capacity (MESH:D000073397), ability (OMIM:313000), neurological diseases (MESH:D020271), Brain Fatigue Syndrome (MESH:D005221), mitochondrial dysfunction (MESH:D028361), sleep disturbances (MESH:D012893), developmental disorders (MESH:D002658), autoimmune conditions (MESH:D001327)
- **Chemicals:** glutamate (MESH:D018698), glucose (MESH:D005947)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12111823/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12111823/full.md

## References

84 references — full list in the complete paper: https://tomesphere.com/paper/PMC12111823/full.md

---
Source: https://tomesphere.com/paper/PMC12111823